These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

347 related articles for article (PubMed ID: 19333143)

  • 1. Novel HMGB1-inhibiting therapeutic agents for experimental sepsis.
    Wang H; Ward MF; Sama AE
    Shock; 2009 Oct; 32(4):348-57. PubMed ID: 19333143
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Therapeutic potential of HMGB1-targeting agents in sepsis.
    Wang H; Zhu S; Zhou R; Li W; Sama AE
    Expert Rev Mol Med; 2008 Nov; 10():e32. PubMed ID: 18980707
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Targeting HMGB1 in the treatment of sepsis.
    Wang H; Ward MF; Sama AE
    Expert Opin Ther Targets; 2014 Mar; 18(3):257-68. PubMed ID: 24392842
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Role of high mobility group box 1 in inflammatory disease: focus on sepsis.
    Bae JS
    Arch Pharm Res; 2012 Sep; 35(9):1511-23. PubMed ID: 23054707
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Caging a Beast in the Inflammation Arena: Use of Chinese Medicinal Herbs to Inhibit a Late Mediator of Lethal Sepsis, HMGB1.
    Zhu S; Li W; Li J; Sama AE; Wang H
    Int J Clin Exp Med; 2008; 1(1):64-75. PubMed ID: 19079688
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A major ingredient of green tea rescues mice from lethal sepsis partly by inhibiting HMGB1.
    Li W; Ashok M; Li J; Yang H; Sama AE; Wang H
    PLoS One; 2007 Nov; 2(11):e1153. PubMed ID: 17987129
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Suppression of HMGB1 release by stearoyl lysophosphatidylcholine:an additional mechanism for its therapeutic effects in experimental sepsis.
    Chen G; Li J; Qiang X; Czura CJ; Ochani M; Ochani K; Ulloa L; Yang H; Tracey KJ; Wang P; Sama AE; Wang H
    J Lipid Res; 2005 Apr; 46(4):623-7. PubMed ID: 15687351
    [TBL] [Abstract][Full Text] [Related]  

  • 8. HMGB1 as a therapeutic target for sepsis: it's all in the timing!
    Gentile LF; Moldawer LL
    Expert Opin Ther Targets; 2014 Mar; 18(3):243-5. PubMed ID: 24479494
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Papaverine identified as an inhibitor of high mobility group box 1/receptor for advanced glycation end-products interaction suppresses high mobility group box 1-mediated inflammatory responses.
    Tamada K; Nakajima S; Ogawa N; Inada M; Shibasaki H; Sato A; Takasawa R; Yoshimori A; Suzuki Y; Watanabe N; Oyama T; Abe H; Inoue S; Abe T; Yokomizo T; Tanuma S
    Biochem Biophys Res Commun; 2019 Apr; 511(3):665-670. PubMed ID: 30826057
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A cardiovascular drug rescues mice from lethal sepsis by selectively attenuating a late-acting proinflammatory mediator, high mobility group box 1.
    Li W; Li J; Ashok M; Wu R; Chen D; Yang L; Yang H; Tracey KJ; Wang P; Sama AE; Wang H
    J Immunol; 2007 Mar; 178(6):3856-64. PubMed ID: 17339485
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Use of animal model of sepsis to evaluate novel herbal therapies.
    Li W; Zhu S; Zhang Y; Li J; Sama AE; Wang P; Wang H
    J Vis Exp; 2012 Apr; (62):. PubMed ID: 22525208
    [TBL] [Abstract][Full Text] [Related]  

  • 12. High-mobility group box-1 isoforms as potential therapeutic targets in sepsis.
    Parrish W; Ulloa L
    Methods Mol Biol; 2007; 361():145-62. PubMed ID: 17172710
    [TBL] [Abstract][Full Text] [Related]  

  • 13. HMGB1 as a potential therapeutic target.
    Wang H; Li W; Goldstein R; Tracey KJ; Sama AE
    Novartis Found Symp; 2007; 280():73-85; discussion 85-91, 160-4. PubMed ID: 17380789
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibitory effects of polyozellin from Polyozellus multiplex on HMGB1-mediated septic responses.
    Yang EJ; Ku SK; Lee W; Song KS; Bae JS
    Inflamm Res; 2015 Sep; 64(9):733-46. PubMed ID: 26206236
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Quercetin prevents LPS-induced high-mobility group box 1 release and proinflammatory function.
    Tang D; Kang R; Xiao W; Zhang H; Lotze MT; Wang H; Xiao X
    Am J Respir Cell Mol Biol; 2009 Dec; 41(6):651-60. PubMed ID: 19265175
    [TBL] [Abstract][Full Text] [Related]  

  • 16. JH-4 reduces HMGB1-mediated septic responses and improves survival rate in septic mice.
    Lee W; Yuseok O; Yang S; Lee BS; Lee JH; Park EK; Baek MC; Song GY; Bae JS
    J Cell Biochem; 2019 Apr; 120(4):6277-6289. PubMed ID: 30378167
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antiseptic effect of vicenin-2 and scolymoside from Cyclopia subternata (honeybush) in response to HMGB1 as a late sepsis mediator in vitro and in vivo.
    Lee W; Yoon EK; Kim KM; Park DH; Bae JS
    Can J Physiol Pharmacol; 2015 Aug; 93(8):709-20. PubMed ID: 26243020
    [TBL] [Abstract][Full Text] [Related]  

  • 18. High mobility group box 1 protein as a potential drug target for infection- and injury-elicited inflammation.
    Zhu S; Li W; Ward MF; Sama AE; Wang H
    Inflamm Allergy Drug Targets; 2010 Mar; 9(1):60-72. PubMed ID: 19906009
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bench to bedside: HMGB1-a novel proinflammatory cytokine and potential therapeutic target for septic patients in the emergency department.
    Sama AE; D'Amore J; Ward MF; Chen G; Wang H
    Acad Emerg Med; 2004 Aug; 11(8):867-73. PubMed ID: 15289194
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Reversing established sepsis with antagonists of endogenous high-mobility group box 1.
    Yang H; Ochani M; Li J; Qiang X; Tanovic M; Harris HE; Susarla SM; Ulloa L; Wang H; DiRaimo R; Czura CJ; Wang H; Roth J; Warren HS; Fink MP; Fenton MJ; Andersson U; Tracey KJ
    Proc Natl Acad Sci U S A; 2004 Jan; 101(1):296-301. PubMed ID: 14695889
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.